Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis: A case control study
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
PURPOSE: A small group of patients with ulcerative colitis (UC) also suffer from primary sclerosing cholangitis (PSC). Genetic and immunologic differences exist between UC patients with and without concomitant PSC. Furthermore, UC patients with PSC are more prone to developing colonic dysplasia/aneuploidy compared with patients with UC only. Because colonic disease activity and treatment with sulfasalazine have been found to be of independent importance for development of colonic carcinoma in UC, this study aims to determine if differences exist concerning colonic disease activity in UC patients with and without PSC. METHODS: Twenty-nine PSC patients with total colitis were matched to two UC patients with total colitis but without liver disease. Case records and questionnaires were used to gain information on pharmacologic treatment and disease activity. RESULTS: Observation time was 20 (PSC group) and 23 years (UC only). Number of patients taking prophylactic treatment did not differ between groups. Patients with UC only had received treatment with systemic and local corticosteroids significantly more often than UC patients with PSC (P < 0.05 and P < 0.02). Patients with UC only were hospitalized because of colonic activity significantly more often (P < 0.02). Number of patients undergoing colectomy because of disease activity or number of patients with chronic continuous symptoms did not differ between the two groups. CONCLUSION: UC in patients with PSC runs a milder course than UC in patients without this complication, although the number of patients taking prophylactic treatment was the same. If lower disease activity reflects differences in pathogenesis of UC in patients with PSC or if it can explain increased risk to develop colonic malignancy in patients with both PSC and UC needs further elucidation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The need for treatment with steroids is reported to be lower than in UC without PSC.363,364”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [363]
Citations
Cites
Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis
Schroeder, K. W., Tremaine, W. J., & Ilstrup, D. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712243172603 · Cited by 3,026
Cortisone in Ulcerative Colitis
Truelove, S. C., & Witts, L. J. (1955) · BMJ · doi:10.1136/bmj.2.4947.1041 · Cited by 2,767
Chapman, R. W., Arborgh, B. A., Rhodes, J. M., Summerfield, J. A., Dick, R., Scheuer, P. J., & Sherlock, S. (1980) · Gut · doi:10.1136/gut.21.10.870 · Cited by 732
Course and prognosis of ulcerative colitis: Part III Complications
Edwards, F. C., & Truelove, S. C. (1964) · Gut · doi:10.1136/gut.5.1.1 · Cited by 687
Clinicopathologic features of the syndrome of primary sclerosing cholangitis
Wiesner, R. H., & LaRusso, N. F. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90131-6 · Cited by 550
Primary sclerosing cholangitis and ulcerative colitis: Evidence for increased neoplastic potential
Broomé, U., Löfberg, R., Veress, B., & Eriksson, L. S. (1995) · Hepatology · doi:10.1002/hep.1840220511 · Cited by 481
Self-citationPrevalence of Primary Sclerosing Cholangitis in Patients With Ulcerative Colitis
Olsson, R., Danielsson, Å., Järnerot, G., Lindström, E., Lööf, L., Rolny, P., Rydén, B.-O., Tysk, C., & Wallerstedt, S. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)70019-t · Cited by 426
Risk factors for colorectal cancer in patients with ulcerative colitis: A case-control study
Pinczowski, D., Ekbom, A., Baron, J., Yuen, J., & Adami, H.-O. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90068-x · Cited by 337
An epidemiological study of ulcerative colitis and regional enteritis in the Oxford area.
Evans, J. G., & Acheson, E. D. (1965) · Gut · doi:10.1136/gut.6.4.311 · Cited by 301
Primary Sclerosing Cholangitis: A Long-Term Follow-up Study
Aadland, E., Schrumpf, E., Fausa, O., Elgjo, K., Heilo, A., Aakhus, T., & Gjone, E. (1987) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528709011139 · Cited by 276
Cited by
Diagnosis and Management of Primary Sclerosing Cholangitis
Chapman, R., Fevery, J., Kalloo, A., Nagorney, D. M., Boberg, K. M., Shneider, B., & Gores, G. J. (2010) · Hepatology · doi:10.1002/hep.23294 · Cited by 1,224
PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis
Loftus, E. V., Harewood, G. C., Loftus, C. G., Tremaine, W. J., Harmsen, W. S., Zinsmeister, A. R., Jewell, D. A., & Sandborn, W. J. (2005) · Gut · doi:10.1136/gut.2004.046615 · Cited by 777
Risk for colorectal cancer in ulcerative colitis: Changes, causes and management strategies
Lakatos, P. L., & Lakatos, L. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3937 · Cited by 442
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma
Bowlus, C. L., Arrivé, L., Bergquist, A., Deneau, M., Forman, L., Ilyas, S. I., Lunsford, K. E., Martinez, M., Sapisochin, G., Shroff, R., et al. (2023) · Hepatology · doi:10.1002/hep.32771 · Cited by 428
EASL Clinical Practice Guidelines on sclerosing cholangitis
Chazouilleres, O., Beuers, U., Bergquist, A., Karlsen, T. H., Levy, C., Samyn, M., Schramm, C., & Trauner, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.05.011 · Cited by 419
Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease
Adams, D. H., & Eksteen, B. (2006) · Nature Reviews Immunology · doi:10.1038/nri1784 · Cited by 307
Cancer surveillance in patients with primary sclerosing cholangitis
Razumilava, N., Gores, G. J., & Lindor, K. D. (2011) · Hepatology · doi:10.1002/hep.24570 · Cited by 292
Bergquist, A., Glaumann, H., Persson, B., & Broomé, U. (1998) · Hepatology · doi:10.1002/hep.510270201 · Cited by 281
Self-citationPrimary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease
Boonstra, K., van Erpecum, K. J., van Nieuwkerk, K. M. J., Drenth, J. P. H., Poen, A. C., Witteman, B. J. M., Tuynman, H. A. R. E., Beuers, U., & Ponsioen, C. Y. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22938 · Cited by 262
Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis
Vries, A. B. D. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i6.1956 · Cited by 253
Colorectal cancer in inflammatory bowel disease: What is the real magnitude of the risk?
Dyson, J. K. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i29.3839 · Cited by 214
Loftus, E. V., Aguilar, H. I., Sandborn, W. J., Tremaine, W. J., Krom, R. A., Zinsmeister, A. R., Graziadei, I. W., & Wiesner, R. H. (1998) · Hepatology · doi:10.1002/hep.510270308 · Cited by 204
Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease
Navaneethan, U., & Shen, B. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21219 · Cited by 201
Papatheodoridis, G. V., Hamilton, M., Mistry, P. K., Davidson, B., Rolles, K., & Burroughs, A. K. (1998) · Gut · doi:10.1136/gut.43.5.639 · Cited by 189
Joo, M., Abreu-e-Lima, P., Farraye, F., Smith, T., Swaroop, P., Gardner, L., Lauwers, G. Y., & Odze, R. D. (2009) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318196d018 · Cited by 184
Verdonk, R. C., Dijkstra, G., Haagsma, E. B., Shostrom, V. K., Van den Berg, A. P., Kleibeuker, J. H., Langnas, A. N., & Sudan, D. L. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01333.x · Cited by 182
Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases
Torres, J., Caprioli, F., Katsanos, K. H., Lobatón, T., Micić, D., Zerôncio, M., Assche, G. V., Lee, J. C., Lindsay, J. O., Rubin, D. T., et al. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw116 · Cited by 180
Jrgensen, K. K., Grzyb, K., Lundin, K. E. A., Clausen, O. P. F., Aamodt, G., Schrumpf, E., Vatn, M. H., & Boberg, K. M. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21699 · Cited by 149
The features of mucosa‐associated microbiota in primary sclerosing cholangitis
Torres, J., Bao, X., Goel, A., Colombel, J. ‐., Pekow, J., Jabri, B., Williams, K. M., Castillo, A., Odin, J. A., Meckel, K., et al. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13552 · Cited by 149
Abnormal hepatic biochemistries in patients with inflammatory bowel disease
Mendes, F. D., Levy, C., Enders, F. B., Loftus, E. V., Angulo, P., & Lindor, K. D. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00947.x · Cited by 147
Saich, R., & Chapman, R. W. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.331 · Cited by 161
Gizard, E., Ford, A. C., Bronowicki, J.-P., & Peyrin-Biroulet, L. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12794 · Cited by 139
Hepatobiliary manifestations in inflammatory bowel disease: The gut, the drugs and the liver
Rojas-Feria, M., Castro, M., Suárez, E., Ampuero, J., & Romero-Gómez, M. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i42.7327 · Cited by 154
Bone disease in patients with primary sclerosing cholangitis
Angulo, P., Grandison, G. A., Fong, D. G., Keach, J. C., Lindor, K. D., Bjornsson, E., & Koch, A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.10.014 · Cited by 133
CANCER RISK IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Lewis, J. D., Deren, J. J., & Lichtenstein, G. R. (1999) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70065-0 · Cited by 132
Lindberg, B. U., Broomé, U., & Persson, B. (2001) · Diseases of the Colon & Rectum · doi:10.1007/bf02234825 · Cited by 121
Self-citationPrimary Sclerosing Cholangitis
Talwalkar, J. A., & Lindor, K. D. (2005) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200501000-00009 · Cited by 137
Epidemiology and Risk Factors for Colorectal Dysplasia and Cancer in Ulcerative Colitis
Loftus, E. V. (2006) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2006.07.005 · Cited by 129
Toy, E., Balasubramanian, S., Selmi, C. F., Li, C., & Bowlus, C. L. (2011) · BMC Gastroenterology · doi:10.1186/1471-230x-11-83 · Cited by 121
Torres, J., de Chambrun, G. P., Itzkowitz, S. H., Sachar, D. B., & Colombel, J. F. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04753.x · Cited by 128
Marelli, L., Xirouchakis, E., Kalambokis, G., Cholongitas, E., Hamilton, M. I., & Burroughs, A. K. (2011) · Gut · doi:10.1136/gut.2010.235408 · Cited by 113
Shah, S. C., ten Hove, J. R., Castaneda, D., Palmela, C., Mooiweer, E., Colombel, J.-F., Harpaz, N., Ullman, T. A., van Bodegraven, A. A., Jansen, J. M., et al. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.01.023 · Cited by 109
“However, despite their mild clinical colitis, patients with PSCIBD compared with patients with only IBD colitis have a 3- to 5-fold higher risk of CRC, and the cancers occur more often in the right colon.(14,15) As such, current guidelines recommend that patients with PSC-IBD be enrolled in a CRC surveillance program…”
BackgroundFaubion, W. A., Loftus, E. V., Sandborn, W. J., Freese, D. K., & Perrault, J. F. (2001) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200109000-00013 · Cited by 104
JAYARAM, H., SATSANGI, J., & CHAPMAN, R. W. G. (2001) · Gut · doi:10.1136/gut.48.3.430 · Cited by 100
Ponsioen, C. Y., Assis, D. N., Boberg, K. M., Bowlus, C. L., Deneau, M., Thorburn, D., Aabakken, L., Färkkilä, M., Petersen, B., Rupp, C., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.07.046 · Cited by 95
The IBD and PSC phenotypes of PSC-IBD
Ricciuto, A., Kamath, B. M., & Griffiths, A. M. (2018) · Current Gastroenterology Reports · doi:10.1007/s11894-018-0620-2 · Cited by 94
Primary sclerosing cholangitis
Silveira, M. G., & Lindor, K. D. (2008) · Canadian Journal of Gastroenterology · doi:10.1155/2008/824168 · Cited by 93
A unique clinical phenotype of primary sclerosing cholangitis associated with Crohn's disease
Halliday, J. S., Djordjevic, J., Lust, M., Culver, E. L., Braden, B., Travis, S. P. L., & Chapman, R. W. G. (2012) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2011.07.015 · Cited by 91
Colorectal Cancer in Inflammatory Bowel Disease
Potack, J., & Itzkowitz, S. H. (2008) · Gut and Liver · doi:10.5009/gnl.2008.2.2.61 · Cited by 88
Florin, T. H., Pandeya, N., & Radford‐Smith, G. L. (2004) · Gut · doi:10.1136/gut.2003.036483 · Cited by 88
Karlsen, T. H., Vesterhus, M., & Boberg, K. M. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12581 · Cited by 86
Inflammatory bowel disease and liver transplantation for primary sclerosing cholangitis
van de Vrie, W., de Man, R. A., van Buuren, H. R., Schouten, W. R., Tilanus, H. W., & Metselaar, H. J. (2003) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200306000-00013 · Cited by 83
Navaneethan, U., Venkatesh, P. G. K., Mukewar, S. S., Lashner, B. A., Remzi, F. H., McCullough, A. J., Kiran, R. P., Shen, B., & Fung, J. J. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.01.006 · Cited by 88
Interactions between chronic liver disease and inflammatory bowel disease
Loftus, E. V., Sandborn, W. J., Lindor, K. D., & Larusso, N. F. (1997) · Inflammatory Bowel Diseases · doi:10.1002/ibd.3780030408 · Cited by 81
Jørgensen, K. K., Lindström, L., Cvancarova, M., Karlsen, T. H., Castedal, M., Friman, S., Schrumpf, E., Foss, A. E., Isoniemi, H., Nordin, A. J., et al. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.12.027 · Cited by 87
Lindström, L., Lapidus, A., Öst, Å., & Bergquist, A. (2011) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0b013e31822bbcc1 · Cited by 77
Ye, B. D., Yang, S.-K., Boo, S.-J., Cho, Y. K., Yang, D.-H., Yoon, S. M., Kim, K. J., Byeon, J.-S., Myung, S.-J., Yu, C. S., et al. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21569 · Cited by 75
Review article: current management of primary sclerosing cholangitis
Cullen, S., & Chapman, R. W. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02407.x · Cited by 82
New therapeutic avenues in ulcerative colitis: thinking out of the box
Torres, J., Danese, S., & Colombel, J. (2013) · Gut · doi:10.1136/gutjnl-2012-303959 · Cited by 74
Liver Disorders in Inflammatory Bowel Disease
Uko, V. E., Thangada, S., & Radhakrishnan, K. R. (2012) · Gastroenterology Research and Practice · doi:10.1155/2012/642923 · Cited by 80
Shen, B., Bennett, A. E., Navaneethan, U., Lian, L., Shao, Z., Kiran, R. P., Fazio, V. W., & Remzi, F. H. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21594 · Cited by 68
Primary sclerosing cholangitis
Rabiee, A., & Silveira, M. G. (2020) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh-20-266 · Cited by 80
Clinical course of ulcerative colitis in patients with and without primary sclerosing cholangitis
MOAYYERI, A., DARYANI, N. E., BAHRAMI, H., HAGHPANAH, B., NAYYER‐HABIBI, A., & SADATSAFAVI, M. (2005) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.03727.x · Cited by 60
Update on inflammatory bowel disease in patients with primary sclerosing cholangitis
Tsaitas, C. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i4.178 · Cited by 59
Primary sclerosing cholangitis
Cullen, S., & Chapman, R. W. (2003) · Autoimmunity Reviews · doi:10.1016/s1568-9972(03)00030-2 · Cited by 60
Culver, E. L., & Chapman, R. W. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04658.x · Cited by 56
Lepistö, A., Kärkkäinen, P., & Järvinen, H. J. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20384 · Cited by 56
Bergquist, A., Said, K., Broomé, U., Bergquist, A., Said, K., & Broomé, U. (2007) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520600787994 · Cited by 55
Self-citationFactors Associated With Poor Outcomes in Adults With Newly Diagnosed Ulcerative Colitis
Reinisch, W., Reinink, A. R., & Higgins, P. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.03.037 · Cited by 61
Primary sclerosing cholangitis: A review and update
Tabibian, J. H., & Bowlus, C. L. (2017) · Liver Research · doi:10.1016/j.livres.2017.12.002 · Cited by 65
Jang, H.-J., Kang, B., & Choe, B. (2019) · Translational Pediatrics · doi:10.21037/tp.2019.01.06 · Cited by 61
Ordonez, F., Lacaille, F., Canioni, D., Talbotec, C., Fournet, J., Cerf–Bensussan, N., Goulet, O., Schmitz, J., & Ruemmele, F. M. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22864 · Cited by 52
Navaneethan, U., Venkatesh, P. G. K., Bennett, A. E., Patel, V., Hammel, J., Kiran, R. P., McCullough, A. J., & Shen, B. (2011) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2011.10.011 · Cited by 47
Surgical Management of Ulcerative Colitis in the Presence of Primary Sclerosing Cholangitis
Poritz, L. S., & Koltun, W. A. (2003) · Diseases of the Colon & Rectum · doi:10.1007/s10350-004-6520-6 · Cited by 46
Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis
Bergquist, A. M., & Broomé, U. (2001) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2001.0210 · Cited by 44
Self-citationSchnitzler, F., Friedrich, M., Stallhofer, J., Schönermarck, U., Fischereder, M., Habicht, A., Mirza‐Schreiber, N., Wolf, C., Angelberger, M., Olszak, T., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135807 · Cited by 45
Conway, G. M., Velonias, G., Andrews, E., Garber, J. J., Yajnik, V., & Ananthakrishnan, A. N. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13940 · Cited by 47
Colonic dysplasia and cancer in inflammatory bowel disease
Judge, T. A., Lewis, J. D., & Lichtenstein, G. R. (2002) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/s1052-5157(02)00014-4 · Cited by 41
Beery, R. M. M., Vaziri, H., & Forouhar, F. (2014) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2014.00024 · Cited by 55
Saubermann, L. J., Deneau, M. R., Falcone, R. A., Murray, K. F., Ali, S. A., Kohli, R., Ekong, U. D., Valentino, P. L., Grossman, A. B., Rand, E. B., et al. (2016) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001492 · Cited by 44
Cancer in inflammatory bowel disease
Sharan, R., & Schoen, R. E. (2002) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(01)00014-0 · Cited by 39
Clinical Predictors of Aggressive/Disabling Disease: Ulcerative Colitis and Crohn Disease
Blonski, W. C., Buchner, A. M., & Lichtenstein, G. R. (2012) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2012.01.008 · Cited by 35
Liu, K., Wang, R., Kariyawasam, V. C., Wells, M., Strasser, S. I., McCaughan, G. W., Corte, C., & Leong, R. W. L. (2016) · Liver International · doi:10.1111/liv.13328 · Cited by 38
Hepatobiliary manifestations of ulcerative colitis: an example of gut-liver crosstalk
Navaneethan, U. (2014) · Gastroenterology report · doi:10.1093/gastro/gou036 · Cited by 36
Infliximab for ulcerative colitis following liver transplantation
Lal, S., & Steinhart, A. H. (2007) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3280116ccc · Cited by 33
Hepatobiliary disorders and complications of inflammatory bowel disease
Venkatesh, P. G. K., Navaneethan, U., & Shen, B. (2011) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2011.00511.x · Cited by 37
Clinical Aspects of Idiopathic Inflammatory Bowel Disease: A Review for Pathologists
Lee, H., Westerhoff, M. A., Shen, B., & Liu, X. (2016) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2015-0305-ra · Cited by 36
Attauabi, M., Zhao, M., Bendtsen, F., & Burisch, J. M. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa167 · Cited by 32
Clinical Practice Guidelines for Surveillance Colonoscopy
Bell, C. J., Price, T. J., Macrae, F., John, D. S., Thwaites, J., & Curtis, T. (2019) · Minerva Access (University of Melbourne) · Cited by 28
Bjarnason, I., Hayee, B., Pavlidis, P., Kvasnovsky, C., Scalori, A., Sisson, G., Charlesworth, A., Shaikh, H., Bjornsson, E. S., & Heneghan, M. A. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.08.041 · Cited by 26
Ulcerative Colitis Complicated with Primary Biliary Cirrhosis
Tada, F., Abe, M., Nunoi, H., Azemoto, N., Mashiba, T., Furukawa, S., Kumagi, T., Murakami, H., Ikeda, Y., Matsuura, B., et al. (2011) · Internal Medicine · doi:10.2169/internalmedicine.50.5919 · Cited by 27
Chemoprevention and screening in primary sclerosing cholangitis
Kitiyakara, T., & Chapman, R. W. (2008) · Postgraduate Medical Journal · doi:10.1136/pgmj.2007.064592 · Cited by 25
Inflammatory Bowel Disease Phenotype in Pediatric Primary Sclerosing Cholangitis
Lascurain, L., Jensen, M. K., Guthery, S. L., Holmen, J. R., & Deneau, M. R. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000586 · Cited by 25
Cholongitas, Ε., Papatheodoridis, G., Zappoli, P., Giannakopoulos, A., Patch, D., Marelli, L., Shusang, V., Kalambokis, G., Shirling, G., Rolando, N., et al. (2007) · Liver Transplantation · doi:10.1002/lt.21077 · Cited by 24
Avoiding Pitfalls: What an Endoscopist Should Know in Liver Transplantation—Part II
Sharma, S., Gurakar, A. O., Camcı, C., & Jabbour, N. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0520-7 · Cited by 22
Liver transplantation and inflammatory bowel disease
Papatheodoridis, G., Hamilton, M., Rolles, K., & Burroughs, A. K. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80359-0 · Cited by 22
Chrisinger, J. S. A., Dassopoulos, T., Yan, Y., & Nalbantoglu, I. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i28.4126 · Cited by 24
Treatment options for primary sclerosing cholangitis
Sinakos, E., & Lindor, K. D. (2010) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.10.33 · Cited by 20
Bramuzzo, M., Martelossi, S., Torre, G., Cardile, S., Arrigo, S., Vignola, S., Ferrari, F., Zuin, G., Illiceto, M. T., Gasparetto, M., et al. (2015) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001078 · Cited by 20
Khan, N., Trivedi, C., Shah, Y., Cole, E., Lewis, J., & Yang, Y.-X. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy106 · Cited by 18
Review article: the relevance of surveillance endoscopy in long‐lasting inflammatory bowel disease
Vleggaar, F. P., Lutgens, M. W. M. D., & Claessen, M. M. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03487.x · Cited by 18
Sclerosing Cholangitis and Recurrent Pyogenic Cholangitis
Ross, A. S., & Kowdley, K. V. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6189-2.00068-8 · Cited by 17
Who and how to screen for cancer in at-risk inflammatory bowel disease patients
Parian, A. M., & Lazarev, M. G. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.1003208 · Cited by 16
Ribaldone, D. G., Imperatore, N., Grazie, M. L., Furfaro, F., Balestrieri, P., BLASIO, F. D., Fagoonee, S., Mosso, E., Boano, V., Reggio, D., et al. (2020) · Digestive and Liver Disease · doi:10.1016/j.dld.2020.09.011 · Cited by 16
Raszeja‐Wyszomirska, J., Kucharski, R., Zygmunt, M., Safranow, K., & Miazgowski, T. (2015) · Hepatitis Monthly · doi:10.5812/hepatmon.25539 · Cited by 15
The colon and PSC: new liver, new danger?
Chapman, R. W. (1998) · Gut · doi:10.1136/gut.43.5.595 · Cited by 15
Osteosarcopenia in autoimmune cholestatic liver diseases: Causes, management, and challenges
Pugliese, N., Arcari, I., Aghemo, A., Lania, A. G., Lleò, A., & Mazziotti, G. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i14.1430 · Cited by 15
Das, T. S., Ho, K., Udaikumar, J., Chen, B., Delau, O., Shaukat, A., Jacobson, I. M., & Sarwar, R. (2024) · Hepatology Research · doi:10.1111/hepr.14029 · Cited by 13
Dohan, A. J. J., Faraoun, S. A., Barral, M., Guerrache, Y., Boudiaf, M., Dray, X., Hoeffel, C. C., Allez, M., Farges, O., Beaugerie, L., et al. (2015) · Diagnostic and Interventional Imaging · doi:10.1016/j.diii.2015.02.009 · Cited by 13
Heuschen, G., Heuschen, U. A., & Herfarth, C. (1998) · Der Chirurg · doi:10.1007/s001040050532 · Cited by 13
Metadata
- Authors
- Lundqvist, K., & Broomé, U.
- Affiliations
- Karolinska Institutet (SE)
- Venue
- Diseases of the Colon & Rectum
- Published
- 1997-04
- Volume
- 40
- Issue
- 4
- Pages
- 451-456
- ISSN
- 0012-3706 (ISSN-L)
- OpenAlex
- W1973889287
- Cited by
- 159
- References
- 24
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 1 · 2022: 5 · 2021: 5 · 2020: 6 · 2019: 3 · 2018: 5 · 2017: 8 · 2016: 8 · 2015: 9 · 2014: 8 · 2013: 7 · 2012: 12
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diseases of the Colon & Rectum (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- ulcerative colitis, primary sclerosing cholangitis, colonic dysplasia, sulfasalazine, corticosteroid therapy, colectomy, clinical course, inflammatory bowel disease
- MeSH terms
- Adrenal Cortex Hormones, Adult, Anti-Inflammatory Agents, Colectomy, Colitis, Ulcerative, Colonic Neoplasms, Female, Hospitalization, Humans, Male, Middle Aged, Surveys and Questionnaires, Sulfasalazine, Cholangitis, Sclerosing, Case-Control Studies, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.